Acasti Pharma Unaware of Any Material Change
LAVAL, Québec, Dec. 23, 2020 (GLOBE NEWSWIRE) -- At the request of IIROC, Acasti Pharma Inc. (“Acasti or the “Company”)...
Day: December 24, 2020
Galapagos’ CEO makes donation of €10 million in the form of personal shares to African Parks
Mechelen, Belgium; 23 December 2020, 18.00 CET – Galapagos NV (Euronext & NASDAQ: GLPG) today announces that Onno van de...
Franklin Woods Center Among the First Long-Term Care Facilities in Maryland to Vaccinate Residents and Healthcare Workers
KENNETT SQUARE, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Franklin Woods Center, a Genesis HealthCare- (NYSE:GEN) (Genesis or the Company)...
LifeLabs Confirms that all Members of Santa’s Workshop Have Tested Negative for COVID-19
Santa and team have been cleared for international travel ahead of Christmas LifeLabs Confirms that all Members of Santa’s Workshop...
Allogene Therapeutics Receives IND Clearance from the U.S. Food and Drug Administration for ALLO-715 in Combination with Nirogacestat in Relapsed/Refractory Multiple Myeloma
Combination Represents One of Allogene’s Three Strategies to Target BCMA for Multiple MyelomaPhase 1 Clinical Trial Expected to Begin in...
Elmcroft by Eclipse Senior Living Begins Vaccinating Residents and Associates
Raymond Gano, a resident at Eclipse Senior Living's Elmcroft of Martinsburg community, receives his vaccination. Raymond Gano, a resident at...
Orbus Therapeutics Receives U.S. Patent for Eflornithine Formulations
- Patent relates to a solution of eflornithine for oral administration currently being evaluated in Orbus’ Phase 3 STELLAR study...
Palvella Therapeutics Reports Top-Line Results from Pivotal Phase 2/3 VALO Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel in Patients with Pachyonychia Congenita
~ VALO Study Misses Primary Endpoint in Phase 3 Randomized Withdrawal Portion ~ ~ VALO Study Achieves Primary Endpoint in...
Vincera Pharma Announces Completion of Business Combination and Listing on Nasdaq
Business combination transaction with LifeSci Acquisition Corp. was completed on December 23, 2020 Combined company renamed Vincera Pharma, Inc., common...
UPDATE – GBS Inc. Announces Pricing of $21.6 Million Initial Public Offering
Will Trade on the Nasdaq Global Market Under Ticker “GBS”NEW YORK, Dec. 23, 2020 (GLOBE NEWSWIRE) -- GBS Inc. (the...
Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
Shares of Yumanity to commence trading on Nasdaq under new ticker symbol “YMTX” on December 23, 2020 $33.6 million common...
Information about mandatory offer of share repurchase
Information about mandatory offer of share repurchase Joint Stock Company “Grindeks” hereby informs that today according to 22nd December, 2020 Financial...
Financing to support Spineway development strategy
Press release Ecully, 22 December 2020, 10 p.m. Financing planNew tranche of Negma convertible bonds In keeping with its development...
Tauriga Sciences Inc. to Expand its Existing Product Line of CBD Infused Bath Bombs, Branded Under the Tauri-Gum Name
12_23 PR image Mint, Blood Orange, Pomegranate Fragrance Tauri-Gum™ Branded Bath Bombs (CBD Infused) This Product Line Expansion Will Include...
Outlook Therapeutics Reports Financial Results for Fiscal Year 2020 and Provides Corporate Update
All planned clinical trials for ONS-5010 / LYTENAVA™ (bevacizumab-vikg) wet AMD BLA now fully enrolled or completedPivotal data expected in...
Therma Bright Signs IR Agreement with Barwicki Investor Relations, Adds $300,000 to Treasury Through Exercise of Warrants and Options; and Grants Options
Toronto, Ontario--(Newsfile Corp. - December 24, 2020) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical...